LitAlert ~~

    • How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer?
    • Kwong A, Ho CYS, Shin VY, Au CH, Chan TL, Ma ESK.
    • BMC Med Genomics. 2022 May 31;15(1):122. doi: 10.1186/s12920-022-01270-4.
    • CHEK2 variants: linking functional impact to cancer risk.
    • Boonen RACM, Vreeswijk MPG, van Attikum H.
    • Trends Cancer. 2022 May 25:S2405-8033(22)00096-6. doi: 10.1016/j.trecan.2022.04.009. Epub ahead of print.